thumbnail image
  • Home
  • About Us
  • Research
  • Services
  • Events
  • Contact Us
  • …  
    • Home
    • About Us
    • Research
    • Services
    • Events
    • Contact Us
    TIC Seminars
    • Home
    • About Us
    • Research
    • Services
    • Events
    • Contact Us
    • …  
      • Home
      • About Us
      • Research
      • Services
      • Events
      • Contact Us
      TIC Seminars
      •  

         

         

         

         

         

         

         

      • About Us

        From imaging research to advanced patient care

        In 2019 the Translational Imaging Center (TIC) has been established at the Campus of the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel AG). Our mission is to enable translational imaging research ranging from molecular chemistry and physics to applied human-oriented research. We employ advanced magnetic resonance imaging closely linked to the clinical environment and the research at the University of Bern and the University Hospital Bern (Inselspital). The heart of our center is an innovative 7 Tesla UHF MRI designed specifically for clinical operation. This FDA and CE-labelled UHF-technology has revolutionized diagnostic imaging in many domains and serves as a diagnostic center for specialized medical indications. Further, with the ongoing paradigm shift from cohorts to personalized medicine, diagnostic imaging and disease monitoring supports the identification of novel biomarkers, metabolomic and radiomic analyses. Through this translational approach we further envision the development of products in the field of medical technology, also offering a unique entrepreneurial platform.

      • Our Partners

        The Translational Imaging Center (TIC) is part of the Inselgruppe AG, the largest and leading medical care system in Switzerland, specifically as a unit within the Department Teaching and Research of the University Hospital. The realization of such a platform is only possible with the support of our key partner organizations, namely the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel AG), a National Center of Excellence that assists in the transition from research findings or prototypes to marketable products, the University of Bern with its 150 institutes and nine inter- and transdisciplinary competence centers and Siemens Healthineers, a world-leading medical device company, that specialises in medical imaging equipment and diagnostics.

      • Organisation

        Management

        Research

        Boards

      • Research

        Shaping the future of MR imaging research in Switzerland

        MRI technology continues to develop rapidly, and increasingly specialized applications have opened up an environment for comprehensive synergistic research areas consisting of life science, medicine and other basic research, including magnetic resonance methods, system biology and biomedical engineering. Working groups from the University Hospital Bern (Inselspital) and the University of Bern have joined forces to form an MRI research consortium with the goal to develop an integrative platform for translational research and education. The platform constitutes one of the core enabling facilities at sitem-insel and aims at leveraging the research from the cellular level up to clinical research. Close collaboration with our industry partners enables the development of novel MRI methods and applications and their translation into advanced and personalized patient care.

        Imaging

        Imaging Core Facilities

         

        Basic Science

        Basic Science & University

         

        Neuroscience

        Life & Neurosciences

         

        Medicine

        Biomedicine, Physiology & Surgery

         

      • Services

        With its many collaboration partners of our MR consortium the TIC provides services and consulting for basic research, clinical research and epidemiological studies with emphasis on imaging. Research encompasses life science, psychiatric research, neurovascular and cardiovascular research, neuro-oncology, pre-surgical epilepsy research, elastography of the liver and many more. Services include consultancy with respect to imaging protocols, sequence optimization, imaging processing and data analysis. Other services can be provided through close cooperation with the clinical trial unit of the Faculty of Medicine of the University of Bern and the Bern University Hospital, Inselspital.

        Project Planning

        Study Hosting

        Study Follow-Up

      • Events

        The Translational Imaging Center hosts scientific and translation seminars and offers Continued Professional Development training events.

        Translationale Medizin
        in der Multiplen Sklerose
        "Von der Forschung in die Praxis"

        27 April 2023

        The Evolution of Field Strength in MR:
        Back to the Future?

        Prof. Dr. Dr. h.c. Jürgen Hennig

        15 March 2023

        The Evolution of SLOW-EPSI for Clinical Use in Glioma Patients at 7T

        Guodong Weng, PhD

        02 March 2023

         

         

        Past Events & Seminars
      • News

        Updates and Achievements

        Recognition of TIC Research at ISMRM &ISMRT 2023 Toronto

        The TIC team is thrilled to announce that the Translational Imaging Center has achieved a significant international success, with a total of 31 scientific peer-reviewed abstracts accepted to be presented at the International Society for Magnetic Resonance in Medicine, 03 - 08 June 2023, Toronto. The research reported covers MRI developments across many organ systems from head to toe, and magnetic field strengths from 1.5T to 7T. The topics of the abstracts range from diffusion-weighted MR spectroscopy of the prostate to the detection of flow in the heart and neuronal currents. The presentations cover 10 oral contributions, 4 power pitches, and numerous posters. The success at this leading scientific congress in the field of MRI is a testament to the TIC's dedication and expertise in the field of noninvasive medical imaging. It demonstrates the TIC's commitment to continuing to push the boundaries of what is possible with MRI technology.

        Link to ISMRM website: 2023 ISMRM Annual Meeting & Exhibition – ISMRM

        Better imaging of Multiple Sclerosis patients

        "Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis"

        M. Rebsamen, R. McKinley, P. Radojewski, M. Pistor, C. Friedli, R. Hoepner, A. Salmen, A. Chan, M. Reyes,

        F. Wagner, R. Wiest, C. Rummel
        Human Brain Mapping October 2022

        Brain morphometry is usually based on non-enhanced (pre-contrast) T1-weighted MRI. However, such dedicated protocols are sometimes missing in clinical examinations. Instead, an image with a contrast agent is often available. The methodology described demonstrates that brain morphometry can be derived reliably from contrast-enhanced MRI using Deep-Learning-based morphometry tools, making additional cases available for analysis and potential future diagnostic morphometry tools.

        Access free here https://doi.org/10.1002/HBM.26117

        Prof. Dr. med. Roland Wiest speaks at INGE St. Symposium 2022

        "New possibilities for neuroscience with 7 Tesla MRI"

        The INGE St. 2022 symposium explored "New possibilities for neuroscience through 7 Tesla MRI".

        Use of Ultra-high-field MRI in the most recent clinical and neuroscientific applications will be highlighted by internationally renowned speakers to foster discussions on how 7 Tesla MRI can advance neuroscience research. The programme harnesses the interaction of researchers from a variety of fields including medicine, cognitive sciences and MR physics to benefit all interested communities.

        More information here INGE St. Symposium 2022

        Prof. Dr. sc. nat. Roland Kreis awarded with the honorary membership of ESMRMB

        This was announced at the recent joint congress of ISMRM and ESMRMB in London. Honorary membership is the highest award granted by the European Society for Magnetic Resonance in Medicine and Biology, the largest society for MR research in Europe. The award was bestowed upon Prof Kreis from the MR Methods Group for his outstanding contributions to research in clinical magnetic resonance, in particular quantitative MR spectroscopy, but also for his longstanding commitment to the society.

        Prof. Dr. rer. soc. Katharine Henke receives SNSF Advanced Grant 

        "Strengthening memory formation for retrieval despite amnesia"

        Prof. Dr. rer. soc. Katharine Henke, Professor of Experimental Psychology and Neuropsychology at the Institute of Psychology, University of Bern and Delegate of the Psychology group of the Neuroscience Cluster of the TIC sitem has been awarded SNSF Advanced Grant funding of CHF 1.5 Mio over 5 years.

        Due to the demographic change, the prevalence of amnesia associated with old age rises. Amnesia is a deficit of episodic memory, which is believed to result from a loss of episodic learning. Yet, research in mice suggests that new episodic memories continue to be formed in amnesia because physical memory traces of newly formed memories were discovered. These memories harboured the complete information content, although they were not retrievable. The physical memory traces were reactivated optogenetically to the point where the memories became consciously retrievable despite amnesia. Hence, learning had survived in residual intact hippocampal-neocortical tissue besides pathology in amnesic mice. No one has tracked conscious and unconscious episodic memories over time in healthy and amnesic humans because the necessary techniques were missing and because traditional memory theories claim that episodic memories are bound to be consciously accessible or are inexistent. Tracking newly formed individual episodic memory traces with high-resolution functional magnetic resonance imaging in healthy individuals and amnesic patients is now feasible in Bern with the advent of ultra high-field magnetic resonance imaging. I will use ultra high-field functional magnetic resonance imaging to track memory traces underlying individual episodic memories in healthy and amnesic humans. We will track the dynamic transitions of newly formed memories and their underlying physical memory traces as these memories change their representational status und the geometric configuration of their traces over the 24 hours following episodic learning. During this consolidation time, some memories are expected to shift from being consciously accessible to being only unconsciously accessible and to being inaccessible (forgotten). We will demonstrate that the access to stored episodic memories can vary dynamically during the memories’ lifetime in healthy and amnesic individuals. Using electrical brain-stimulation we will reinforce the physical memory traces of newly formed memories in healthy and amnesic individuals to bring unconscious memories to conscious access. To uncover the mechanism of this strengthening of memory traces, we will use ultra high-field magnetic resonance spectroscopy. We expect brain stimulation-induced local glutamatergic increases to result from an enhanced long-term potentiation that results from electrical brain stimulation.

        ISMRM Prize - Best abstract in "Clinical Research and Applications" at 7T

        "High-resolution T1 atlas for subject-specific abnormality detection at 7T”

        Gian Franco Piredda1,2,3, Piotr Radojewski4,5 ,Gabriele Bonanno5,6,7, Arun Joseph5,6,7, Karl Egger8, Shan Yang8, Punith B. Venkategowda9, Ricardo A. Corredor Jerez1,2,3, Bénédicte Maréchal1,2,3, Roland Wiest4,5, Jean-Philippe Thiran2,3, Tom Hilbert1,2,3, Tobias Kober1,2,3

        1Advanced Clinical Imaging Technology, Siemens Healthcare AG, Lausanne, Switzerland,

        2Department of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland,

        3LTS5, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland,

        4Support Center for Advanced Neuroimaging, Institute for Diagnostic and Interventional Neuroradiology, Inselspital, Bern University, Bern, Switzerland,

        5Translational Imaging Center (TIC), Swiss Institute for Translational and Entrepreneurial Medicine, Bern Switzerland

        6Advanced Clinical Imaging Technology, Siemens Healthcare AG, Bern, Switzerland,

        7Magnetic Resonance Methodology, Institute of Diagnostic and Interventional Neuroradiology, University of Bern, Bern, Switzerland,

        8Department of Neuroradiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany,

        9Siemens Healthcare Pvt. Ltd., Bangalore, India.

        A joint collaboration was awarded best abstract at the 2022 ISMRM Prize in the category of “Clinical Research and Applications” of the High Field Systems and Applications study group. MRI studies conducted at 3T have shown that T1 relaxometry enables personalized characterization of brain tissues by comparing physical properties of a single patient to a normative atlas. Ultra-high field imaging allows exploiting this concept at even higher resolutions, which can be crucial to detect certain diseases. In this study we established an atlas of normative T1 values at 7T from acquisitions with 0.6 mm isotropic resolution. We investigated the clinical potential of 7T vs. 3T imaging in case reports from patients scanned at both field strengths. Our findings suggest that quantitative MR imaging at 7T allows improving the characterization of tissue abnormalities on a single-subject basis compared to 3T.

        Mission Deuterium

        "Metabolic imaging of the brain at ultra high field MRI: feasibility study of spectroscopic methods for exploration of brain metabolism without ionizing radiation"

        Principle Investigator: Prof. Johannes Slotboom of the SCAN/TIC, Neuroradiology

        University Hospital Bern Switzerland

        The aim of this Swiss National Science Foundation project is to study the metabolism in the aging brain. Glucose is the main source of energy if the human brain, and tight regulation of its metabolism is critical for brain physiology. Positron Emission Tomography (PET), which requires an injection of a radioactive substance, is the method most commonly used to study the uptake of glucose in the brain. Deuterium metabolic imaging (DMI) is a novel radiation-free magnetic resonance spectroscopic imaging approach to measure not only the glucose uptake in the brain, but also its metabolic products glutamate and lactate. Beyond glucose, important neurotransmitters (GABA and glutamate) will be studied using a novel approach based on proton magnetic resonance spectroscopic imaging recently developed by our group.

         

        The research will be performed in collaboration of the Support Centre for Advanced Neuroimaging (SCAN), Institute for Diagnostic and Interventional Neuroradiology, Inselspital, Bern; Translational Imaging Center of the Sitem-insel AG; the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern; University Hospital of Old Age Psychiatry and Psychotherapy, University of Bern, and the Department of Radiology, University of Miami School of Medicine, Miami, Florida, U.S.A. and the Radiology & Biomedical Imaging Group of the Yale School of Medicine, New Haven, U.S.A.

        Spotting intracranial aneurysms with 7T MRI

        "Clinical Implementation of 7T MRI for the Identification of Incidental Intracranial Aneurysms versus Anatomic Variants"

        P. Radojewski, J. Slotboom, A. Joseph, R. Wiest and P. Mordasini
        American Journal of Neuroradiology October 2021

        Most unruptured intracranial aneurysms can be adequately characterized using 1.5T and 3T MR imaging. Findings in a subgroup of patients can remain unclear due to difficulties in distinguishing aneurysms from vascular anatomic variants. We retrospectively analyzed clinical data from 30 patients with suspected incidental aneurysms on 3T MR imaging who underwent 7T MR imaging. Our findings suggest that 7T MR imaging provides a clarification tool for the group of patients with suspected unruptured intracranial aneurysms and diagnostic ambiguity after standard 3T MR imaging.

        Access free here www.ajnr.org/content/42/12/2172

      • Publications

        Find the recent TIC publications here

      • Contact Us

        For Information on Services and Activities

        Freiburgstrasse 3, 3010 Bern, Switzerland
        +41 79 663 65 45
        +41 79 663 65 45
        info@tic-sitem.ch
        Submit

      Imprint

       

      News

      Contact Us

      +41 79 663 65 45

      info@tic-sitem.ch

      © 2021 TIC. All rights reserved

        All Posts
        ×
        Cookie Use
        We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
        Learn More